Ovestin (Estriol)

Estriol, the active ingredient in Ovestin, is an estrogen hormone presented as a vaginal cream for topical use. It is employed to alleviate estrogen‑deficiency symptoms, particularly in post‑menopausal women. GNH USA supplies Ovestin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ovestin, an estrogen hormone, acts on the estrogen‑deficient pathways associated with menopause. - Menopausal vulvovaginal atrophy: restores moisture and reduces discomfort in the vaginal mucosa. - Urogenital atrophy: improves urinary symptoms and tissue health in the lower genital tract. - Mild systemic estrogen deficiency: alleviates occasional hot flashes and night sweats in post‑menopausal women.

Estriol therapy may be associated with a range of adverse reactions.

Common Side Effects: - Vaginal irritation or burning. - Mild breast tenderness. - Headache. - Nausea. - Light spotting or breakthrough bleeding.

Serious or Rare Side Effects: - Endometrial hyperplasia or carcinoma. - Deep vein thrombosis or pulmonary embolism. - Stroke or myocardial infarction. - Severe allergic reaction (anaphylaxis). - Liver function abnormalities.

Before initiating estriol therapy, consider the following precautions. - Contraindications: avoid use in women with known estrogen‑dependent tumors or active thromboembolic disease. - Monitoring: periodic assessment of breast and pelvic health is recommended. - Drug interactions: review concomitant medications that affect estrogen metabolism. - Pregnancy and lactation: estriol is not recommended during pregnancy or while breastfeeding. - Storage: Store at room temperature below 25°C: keep in the original container, protect from moisture and direct sunlight.

Estriol may interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Combined oral contraceptives: increased risk of thromboembolic events. - Anticoagulants (e.g., warfarin): potential alteration of anticoagulant effect. - Hepatic enzyme inducers (e.g., rifampin): may reduce estriol efficacy.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): may affect estrogen metabolism. - Antihypertensive agents: possible changes in blood pressure control. - Thyroid hormone replacement: monitor thyroid function tests.